Contact Us
Swine Flu Vaccination Global Market Report 2025
Global Swine Flu Vaccination Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Swine Flu Vaccination Global Market Report 2025

By Vaccine Type (Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type), By Treatment Type (Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella), By End User (Hospital, Clinic, Other End User) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Swine Flu Vaccination Market Overview

• Swine Flu Vaccination market size has reached to $13.99 billion in 2024

• Expected to grow to $19.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%

• Growth Driver: Government Immunization Initiatives Impact On The Growth Of Influenza Vaccinations

• Market Trend: Innovative Vaccine To Strengthen Position In Swine Flu Vaccination Market

North America was the largest region in 2024.

What Is Covered Under Swine Flu Vaccination Market?

Swine flu vaccination refers to vaccines designed to protect against the influenza viruses that commonly infect pigs (swine flu). The purpose of vaccines is to prevent transmission of swine flu from pigs to humans.

The main vaccine types of the swine flu vaccination market are intranasal, toxoid, conjugate, inactivated vaccine, attenuated vaccine, and others. An intranasal vaccine is a type of vaccine that is administered through the nose. It stimulates the immune system to protect against specific diseases by introducing weakened or dead pathogens. The various treatment types include influenza, meningococcal, cervical cancer, pneumococcal, hepatitis, measles, mumps, and Rubella and are used by various end users including hospitals, clinics, and others.

Swine Flu Vaccination Market Size and growth rate 2025 to 2029: Graph

What Is The Swine Flu Vaccination Market Size 2025 And Growth Rate?

The swine flu vaccination market size has grown strongly in recent years. It will grow from $13.99 billion in 2024 to $14.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the increasing prevalence of flu, declining immunity among the geriatric population, increasing incidence of swine flu cases, government initiatives towards immunization programs, and advancements in vaccine production and distribution.

What Is The Swine Flu Vaccination Market Growth Forecast?

The swine flu vaccination market size is expected to see strong growth in the next few years. It will grow to $19.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing demand for intramuscular vaccines, increasing awareness of new technologies in vaccination, increasing rate of elderly population, the need for vaccinations to protect the public's health, increased incidence of disease and episodes of pandemic worldwide from h1n1 infection. Major trends in the forecast period include technological advancement, business expansions, product launches, strategic mergers and acquisitions, and partnerships among pharmaceutical firms.

The forecast of 6.7% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for pandemic preparedness by increasing costs for adjuvanted H1N1 vaccines and single-dose syringes imported from India and Brazil, potentially delaying mass vaccination efforts and raising public health costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Swine Flu Vaccination Market Segmented?

1) By Vaccine Type: Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type

2) By Treatment Type: Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella

3) By End User: Hospital, Clinic, Other End User

1) By Intranasal: Live Attenuated Intranasal Vaccines, Inactivated Intranasal Vaccines

2) By Toxoid: Formaldehyde-Inactivated Toxoid Vaccines

3) By Conjugate: Protein Conjugate Vaccines

4) By Inactivated Vaccine: Injectable Inactivated Vaccines, Inactivated Subunit Vaccines

5) By Attenuated Vaccine: Live Attenuated Influenza Vaccines

6) By Other Vaccine Type: DNA Vaccines, Recombinant Vaccines

What Is Driving The Swine Flu Vaccination Market? Government Immunization Initiatives Impact On The Growth Of Influenza Vaccinations

The government initiatives toward vaccination programs are expected to propel the growth of the swine flu vaccination market going forward. Government initiatives toward vaccination programs refer to policies and actions undertaken by governments to promote and facilitate vaccination campaigns. The swine flu vaccination incentivizes governments to prioritize immunization programs by providing necessary vaccines and resources to combat outbreaks effectively, bolstering public health initiatives. For instance, in September 2024, according to reports published by the Centers for Disease Control and Prevention, a US-based national public health agency responsible for controlling the introduction and spread of infectious diseases, during the 2023–24 flu season, 55.4% of children aged 6 months to 17 years received at least one dose of the flu vaccine. Also, the government has allocated 9.3 million doses of adult influenza vaccine to establish a stockpile in case of supply issues. Therefore, the increasing government initiatives toward vaccination programs are driving the growth of the swine flu vaccination industry.

Who Are The Major Players In The Global Swine Flu Vaccination Market?

Major companies operating in the swine flu vaccination market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Mylan N.V., Moderna Inc., Baxter International Inc., Zoetis Inc., Elanco Animal Health, Cipla Inc., Lupin Ltd., Virbac S.A, Sinovac Biotech Ltd., Serum Institute of India Private Limited., Vetoquinol S.A, IDT Biologika GmbH, Bharat Biotech International Limited, Medicago Inc., Panacea Biotec, Hipra

What Are The Key Trends Of The Global Swine Flu Vaccination Market? Innovative Vaccine To Strengthen Position In Swine Flu Vaccination Market

Major companies operating in the swine flu vaccination market are focused on developing innovative products such as the quadrivalent influenza vaccine, to strengthen their position in the market. A quadrivalent influenza vaccine is a type of flu vaccine designed to protect against four different influenza virus strains. For instance, in March 2024, Cadila Pharmaceuticals, an Indian-based pharmaceutical company, announced the launch of the cutting-edge quadrivalent influenza vaccine, Cadiflu Tetra, to prevent influenza. The Cadiflu Tetra Vaccine is a quadrivalent formulation targeting four influenza virus subtypes A and B strains. Its nano-sized particle technology mimics the virus's external structure, enhancing efficacy and safety without containing intact genetic material. This advanced approach improves protection against multiple influenza strains, offering a technologically superior solution for preventing seasonal epidemics.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Swine Flu Vaccination Market? Alopexx and Bharat Biotech Partner to Develop Broad-Spectrum Antimicrobial Vaccine for Global Health

In September 2024, Alopexx, Inc., a US-based clinical-stage biotechnology company, partnered with Bharat Biotech. The partnership aims to co-develop and commercialize Alopexx's broad-spectrum antimicrobial vaccine, AV0328, to address critical infectious disease needs in low- and middle-income countries, reducing antimicrobial resistance. This collaboration combines Bharat Biotech’s expertise in vaccine development with Alopexx’s innovative technology to make affordable, high-quality vaccines widely accessible. Bharat Biotech is an India-based manufacturer of swine flu vaccines.

What Is The Regional Outlook For The Global Swine Flu Vaccination Market?

North America was the largest region in the Swine Flu Vaccination market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Swine Flu Vaccination Market?

The swine flu vaccination market includes revenues earned by entities by vaccine administration, assessment and screening, documentation and record-keeping, and follow-up and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The swine flu vaccination market consists of sales of fluMist quadrivalent, FluLaval quadrivalent, Fluzone quadrivalent, and afluria quadrivalent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Swine Flu Vaccination Industry?

The swine flu vaccination market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the swine flu vaccination industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Swine Flu Vaccination Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $14.95 billion
Revenue Forecast In 2034 $19.35 billion
Growth Rate CAGR of 6.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Vaccine Type: Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type
2) By Treatment Type: Influenza, Meningococcal, Cervical Cancer, Pneumococcal, Hepatitis, Measles, Mumps, Rubella
3) By End User: Hospital, Clinic, Other End User 1) By Intranasal: Live Attenuated Intranasal Vaccines, Inactivated Intranasal Vaccines
2) By Toxoid: Formaldehyde-Inactivated Toxoid Vaccines
3) By Conjugate: Protein Conjugate Vaccines
4) By Inactivated Vaccine: Injectable Inactivated Vaccines, Inactivated Subunit Vaccines
5) By Attenuated Vaccine: Live Attenuated Influenza Vaccines 6) By Other Vaccine Type: DNA Vaccines, Recombinant Vaccines
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Mylan N.V., Moderna Inc., Baxter International Inc., Zoetis Inc., Elanco Animal Health, Cipla Inc., Lupin Ltd., Virbac S.A, Sinovac Biotech Ltd., Serum Institute of India Private Limited., Vetoquinol S.A, IDT Biologika GmbH, Bharat Biotech International Limited, Medicago Inc., Panacea Biotec, Hipra
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Swine Flu Vaccination Market Characteristics

3. Swine Flu Vaccination Market Trends And Strategies

4. Swine Flu Vaccination Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Swine Flu Vaccination Growth Analysis And Strategic Analysis Framework

5.1. Global Swine Flu Vaccination PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Swine Flu Vaccination Market Growth Rate Analysis

5.4. Global Swine Flu Vaccination Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Swine Flu Vaccination Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Swine Flu Vaccination Total Addressable Market (TAM)

6. Swine Flu Vaccination Market Segmentation

6.1. Global Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intranasal

Toxoid

Conjugate

Inactivated Vaccine

Attenuated Vaccine

Other Vaccine Type

6.2. Global Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Influenza

Meningococcal

Cervical Cancer

Pneumococcal

Hepatitis

Measles

Mumps

Rubella

6.3. Global Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Clinic

Other End User

6.4. Global Swine Flu Vaccination Market, Sub-Segmentation Of Intranasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Intranasal Vaccines

Inactivated Intranasal Vaccines

6.5. Global Swine Flu Vaccination Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Formaldehyde-Inactivated Toxoid Vaccines

6.6. Global Swine Flu Vaccination Market, Sub-Segmentation Of Conjugate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Conjugate Vaccines

6.7. Global Swine Flu Vaccination Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Inactivated Vaccines

Inactivated Subunit Vaccines

6.8. Global Swine Flu Vaccination Market, Sub-Segmentation Of Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Influenza Vaccines

6.9. Global Swine Flu Vaccination Market, Sub-Segmentation Of Other Vaccine Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

DNA Vaccines

Recombinant Vaccines

7. Swine Flu Vaccination Market Regional And Country Analysis

7.1. Global Swine Flu Vaccination Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Swine Flu Vaccination Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Swine Flu Vaccination Market

8.1. Asia-Pacific Swine Flu Vaccination Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Swine Flu Vaccination Market

9.1. China Swine Flu Vaccination Market Overview

9.2. China Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Swine Flu Vaccination Market

10.1. India Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Swine Flu Vaccination Market

11.1. Japan Swine Flu Vaccination Market Overview

11.2. Japan Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Swine Flu Vaccination Market

12.1. Australia Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Swine Flu Vaccination Market

13.1. Indonesia Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Swine Flu Vaccination Market

14.1. South Korea Swine Flu Vaccination Market Overview

14.2. South Korea Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Swine Flu Vaccination Market

15.1. Western Europe Swine Flu Vaccination Market Overview

15.2. Western Europe Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Swine Flu Vaccination Market

16.1. UK Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Swine Flu Vaccination Market

17.1. Germany Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Swine Flu Vaccination Market

18.1. France Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Swine Flu Vaccination Market

19.1. Italy Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Swine Flu Vaccination Market

20.1. Spain Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Swine Flu Vaccination Market

21.1. Eastern Europe Swine Flu Vaccination Market Overview

21.2. Eastern Europe Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Swine Flu Vaccination Market

22.1. Russia Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Swine Flu Vaccination Market

23.1. North America Swine Flu Vaccination Market Overview

23.2. North America Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Swine Flu Vaccination Market

24.1. USA Swine Flu Vaccination Market Overview

24.2. USA Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Swine Flu Vaccination Market

25.1. Canada Swine Flu Vaccination Market Overview

25.2. Canada Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Swine Flu Vaccination Market

26.1. South America Swine Flu Vaccination Market Overview

26.2. South America Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Swine Flu Vaccination Market

27.1. Brazil Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Swine Flu Vaccination Market

28.1. Middle East Swine Flu Vaccination Market Overview

28.2. Middle East Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Swine Flu Vaccination Market

29.1. Africa Swine Flu Vaccination Market Overview

29.2. Africa Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Swine Flu Vaccination Market Competitive Landscape And Company Profiles

30.1. Swine Flu Vaccination Market Competitive Landscape

30.2. Swine Flu Vaccination Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

31. Swine Flu Vaccination Market Other Major And Innovative Companies

31.1. Abbott Laboratories

31.2. Novartis AG

31.3. GlaxoSmithKline plc

31.4. Boehringer Ingelheim International GmbH

31.5. Mylan N.V.

31.6. Moderna Inc.

31.7. Baxter International Inc.

31.8. Zoetis Inc.

31.9. Elanco Animal Health

31.10. Cipla Inc.

31.11. Lupin Ltd.

31.12. Virbac S.A

31.13. Sinovac Biotech Ltd.

31.14. Serum Institute of India Private Limited.

31.15. Vetoquinol S.A

32. Global Swine Flu Vaccination Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Swine Flu Vaccination Market

34. Recent Developments In The Swine Flu Vaccination Market

35. Swine Flu Vaccination Market High Potential Countries, Segments and Strategies

35.1 Swine Flu Vaccination Market In 2029 - Countries Offering Most New Opportunities

35.2 Swine Flu Vaccination Market In 2029 - Segments Offering Most New Opportunities

35.3 Swine Flu Vaccination Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Swine Flu Vaccination Market, Sub-Segmentation Of Intranasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Swine Flu Vaccination Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Swine Flu Vaccination Market, Sub-Segmentation Of Conjugate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Swine Flu Vaccination Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Swine Flu Vaccination Market, Sub-Segmentation Of Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Swine Flu Vaccination Market, Sub-Segmentation Of Other Vaccine Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Swine Flu Vaccination Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Swine Flu Vaccination Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Roche Holding AG Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: Sanofi S.A. Financial Performance
  • Table 84: AstraZeneca Plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Swine Flu Vaccination Market, Sub-Segmentation Of Intranasal, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Swine Flu Vaccination Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Swine Flu Vaccination Market, Sub-Segmentation Of Conjugate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Swine Flu Vaccination Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Swine Flu Vaccination Market, Sub-Segmentation Of Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Swine Flu Vaccination Market, Sub-Segmentation Of Other Vaccine Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Swine Flu Vaccination Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Swine Flu Vaccination Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Swine Flu Vaccination Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Swine Flu Vaccination Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Swine Flu Vaccination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Roche Holding AG Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: Sanofi S.A. Financial Performance
  • Figure 84: AstraZeneca Plc Financial Performance

Frequently Asked Questions

Swine flu vaccination refers to vaccines designed to protect against the influenza viruses that commonly infect pigs (swine flu). The purpose of vaccines is to prevent transmission of swine flu from pigs to humans. For further insights on this market, request a sample here

The market major growth driver - Government Immunization Initiatives Impact On The Growth Of Influenza Vaccinations. For further insights on this market, request a sample here

The swine flu vaccination market size has grown strongly in recent years. It will grow from $13.99 billion in 2024 to $14.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the increasing prevalence of flu, declining immunity among the geriatric population, increasing incidence of swine flu cases, government initiatives towards immunization programs, and advancements in vaccine production and distribution. The swine flu vaccination market size is expected to see strong growth in the next few years. It will grow to " $19.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing demand for intramuscular vaccines, increasing awareness of new technologies in vaccination, increasing rate of elderly population, the need for vaccinations to protect the public's health, increased incidence of disease and episodes of pandemic worldwide from h1n1 infection. Major trends in the forecast period include technological advancement, business expansions, product launches, strategic mergers and acquisitions, and partnerships among pharmaceutical firms. For further insights on this market, request a sample here

The swine flu vaccinationmarket covered in this report is segmented –
1) By Vaccine Type: Intranasal; Toxoid; Conjugate; Inactivated Vaccine; Attenuated Vaccine; Other Vaccine Type
2) By Treatment Type: Influenza; Meningococcal; Cervical Cancer; Pneumococcal; Hepatitis; Measles; Mumps; Rubella
3) By End User: Hospital; Clinic; Other End User Subsegments:
1) By Intranasal: Live Attenuated Intranasal Vaccines; Inactivated Intranasal Vaccines
2) By Toxoid: Formaldehyde-Inactivated Toxoid Vaccines
3) By Conjugate: Protein Conjugate Vaccines
4) By Inactivated Vaccine: Injectable Inactivated Vaccines; Inactivated Subunit Vaccines
5) By Attenuated Vaccine: Live Attenuated Influenza Vaccines
6) By Other Vaccine Type: DNA Vaccines; Recombinant Vaccines For further insights on this market,
request a sample here

North America was the largest region in the Swine Flu Vaccination market in 2024. The regions covered in the swine flu vaccination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the swine flu vaccination market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Mylan N.V., Moderna Inc., Baxter International Inc., Zoetis Inc., Elanco Animal Health, Cipla Inc., Lupin Ltd., Virbac S.A, Sinovac Biotech Ltd., Serum Institute of India Private Limited., Vetoquinol S.A, IDT Biologika GmbH, Bharat Biotech International Limited, Medicago Inc., Panacea Biotec, Hipra . For further insights on this market, request a sample here.

Major trends in this market include Innovative Vaccine To Strengthen Position In Swine Flu Vaccination Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top